Amicus Therapeutics completes enrollment in Phase III epidermolysis bullosa study

Press/Media: Press / Media

PeriodApr 3 2017

Media coverage

1

Media coverage

  • TitleAmicus Therapeutics completes enrollment in Phase III epidermolysis bullosa study
    Media name/outletMarketLine NewsWire (Formerly Datamonitor)
    CountryUnited Kingdom
    Date4/3/17
    PersonsJohn C Browning